Alyeska Investment Group, L.P. - PHASEBIO PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 53 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of PHASEBIO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$893,000
+50.8%
68,054
-64.5%
0.01%
+33.3%
Q4 2018$592,000–191,602–0.01%–
 Download
Other shareholders

There were no reported owners of PHASEBIO PHARMACEUTICALS INC in Q2 2019.

NameSharesValueWeighting ↓
View complete list of PHASEBIO PHARMACEUTICALS INC shareholders